Patent assignee · US · UNIVERSITY

Midwestern University

16Patents
16Active
16Granted
49Portfolio score

Filing activity: Aug 19, 2008 → Dec 11, 2020 · 1 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US8980874B2 Method and composition for treating diabetic ketoacidosis Human Necessities 4 Active
US8623823B2 Methods for treatment of stroke or cerebrovascular accidents using an ETB receptor agonist Chemistry; Metallurgy 2 Active
US9493524B2 Methods for treatment of stroke or cerebrovascular accidents using an ETB receptor agonist Human Necessities 2 Active
US9771356B2 Inhibitors of beta-hydroxylase for treatment of cancer Chemistry; Metallurgy 2 Active
US10561704B2 Compositions and methods for treating neuropsychiatric disorders using an endothelin-B receptor agonist Human Necessities 1 Active
US10112981B2 Methods for treatment of stroke or cerebrovascular accidents using an ETB receptor agonist Chemistry; Metallurgy 1 Active
US10106532B2 Inhibitors of beta-hydroxylase for treatment of cancer Chemistry; Metallurgy 0 Active
US10961211B2 Isotopically-stabilized tetronimide compounds Chemistry; Metallurgy 0 Active
US11897857B2 Isotopically-stabilized tetronimide compounds Chemistry; Metallurgy 0 Active
US10351555B2 Inhibitors of β-hydroxylase for treatment of cancer Chemistry; Metallurgy 0 Active
US10688195B2 Polymyxin B-coated nanoparticles Performing Operations; Transporting 0 Active
US10961320B2 Monoclonal antibodies targeting epitopes of ASPH Chemistry; Metallurgy 0 Active
US10828368B2 Therapeutic treatments using centhaquin Human Necessities 0 Active
US10710995B2 Inhibitors of β-hydroxylase for treatment of cancer Chemistry; Metallurgy 0 Active
US11236178B2 Methods of using monoclonal antibodies targeting epitopes of ASPH Chemistry; Metallurgy 0 Active
US10787445B2 Inhibitors of beta-hydroxylase for treatment of cancer Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.